Evidence map›Paper›PMID 35713361›Full record

ArticleImmunology and cell biology2022

SATB1 ensures appropriate transcriptional programs within naïve CD8

Simone Nüssing, Lisa A Miosge, Kah Lee, Moshe Olshansky, Adele Barugahare, Carla M Roots, Yovina Sontani, E Bridie Day, Marios Koutsakos, Katherine Kedzierska and 4 more

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Immunology and cell biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Active maintenance of CD8Cell reports · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Simone NüssingDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC, Australia.
Lisa A MiosgeJohn Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
Kah LeeDepartment of Microbiology, Immunity Theme, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Moshe OlshanskyDepartment of Microbiology, Immunity Theme, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Adele BarugahareBioinformatics Platform, Monash University, Clayton, VIC, Australia.
Carla M RootsJohn Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
Yovina SontaniJohn Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.
E Bridie DayDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC, Australia.
Marios KoutsakosDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC, Australia.
Katherine KedzierskaDepartment of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, University of Melbourne, Parkville, VIC, Australia.ORCID 0000-0001-6141-335X
Christopher C GoodnowJohn Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.ORCID 0000-0001-5296-6155
Brendan E RussDepartment of Microbiology, Immunity Theme, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Stephen R DaleyJohn Curtin School of Medical Research, Australian National University, Canberra, ACT, Australia.ORCID 0000-0002-5870-644X
Stephen J TurnerDepartment of Microbiology, Immunity Theme, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Australian National University · AUDiscovery Institute · USThe University of Melbourne · AUMelbourne Bioinformatics · AU

Funding

Systems Biology CoreU19AI100627 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2012 to 2021
$49.1M
Systems Approach to Innate Immunity-Inflammation-SepsisU54AI054523 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI ULEVITCH, RICHARD J · 2002 to 2006
$28.0M
Genes for Tolerance and Immunity ConsortiumR01AI052127 · NIAID · AUSTRALIAN NATIONAL UNIVERSITY · PI GOODNOW, CHRISTOPHER CARL · 2002 to 2006
$6.3M
NIAID NIH HHS R01 AI052127NIAID NIH HHS U19 AI100627NIAID NIH HHS U54 AI054523
6 · The paper itself

Abstract

Special AT-binding protein 1 (SATB1) is a chromatin-binding protein that has been shown to be a key regulator of T-cell development and CD4

Indexed as

Influenza A virusMatrix Attachment Region Binding ProteinsAnimalsCD8-Positive T-LymphocytesCell DifferentiationLymphocyte ActivationMiceMatrix Attachment Region Binding ProteinsSatb1 protein, mouseCD8+ T cellchromatininfluenza A virusmemory T cellnaïve T cell

Identifiers

PMID35713361
PMCPMC9542893
OpenAlexW4283074198

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.